Enantia is a privately held company devoted to medicinal chemistry, chemical research and development, custom synthesis and crystal engineering, with a strong focus on asymmetric chemistry and co-crystallization technologies. Our mission is to provide fully integrated chemistry services for the fine chemical, pharmaceutical and biotech sectors. We can contribute all the way from initial research in medicinal chemistry or route scouting to any phase of the chemical R&D process. Moreover, Enantia has applied its chemical expertise to provide the marketplace with extremely pure cannabinoids obtained through chemical synthesis. Our catalogue includes CBD produced in GMP conditions in a multi-kilo scale, and also minor cannabinoids as CBG, CBN, CBDV, and CBC. Their outstanding quality is the perfect match for pharmaceuticals, nutraceuticals, cosmetics, edibles and for all those companies that want to excel with a high-quality product.